NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sigma Genetics

Sigma Genetics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://sigmagenetics.com/

Last Round

Seed

May 7, 2026

Est. Valuation

$1.71M

Total Funding Raised

$3.74M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sigma Genetics is a biotechnology company that develops gene delivery platforms, including the Magnetoporator™ device, to enable scalable and high-efficiency cell engineering for drug discovery and therapeutic manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

gene deliverymagnetoporationcell therapytransfectionbioprocessingcell engineeringbiotech equipmentintracellular deliveryclinical manufacturingbiomanufacturinglab automationnon-viral deliveryCDMObiotech hardwaredefense biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sigma Genetics Comparables

Compare Sigma Genetics with similar companies based on industry and business-model similarity.

Sigma Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Sigma Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 7, 2026
AcceleratorMar 23, 2026
GrantAug 8, 2023
SeedJan 27, 2022
AcceleratorMar 1, 2017

Key People

Founding team and executive leadership

Zachary R.

Co-Founder & CEO

Founding Team

Sigma Genetics Investors

Notable investors and investment history

Sigma Genetics investors
InvestorRounds
Plug and Play Tech CenterAccelerator
Capital FactorySeed
Asymmetry VenturesSeed
Y CombinatorAccelerator, Seed
Healthspan CapitalSeed
AFVenturesGrant
Biosphere Investment GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 46% month-over-month.

Sigma Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sigma Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sigma Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range6
Year Founded2016
Last FundingMay 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.